LevitasBio Announces LeviCell EOS System: A New Era in Sample Processing and Characterization


LevitasBio, Inc. today introduced the LeviCell ™ SystemEOS, your next-generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells. Using field-proven Levitation Technology, researchers can now effectively scale their experiments up to 16x and process up to 40 million cells per run. The LeviCell EOS System debuts, along with the new LeviPrep and LeviSelect product lines for tissue dissociation and targeted cell selection, at the 2022 American Association for Cancer Research General Meeting taking place from 8 to April 13 in New Orleans, Louisiana.

Unprecedented scalability and sample throughput

LevitasBio first revolutionized sample preparation in 2020 with the launch of the LeviCell system, which presented researchers with a subtle, fast, and unbiased method of separating and enriching cells of interest through magnetic levitation. Less than two years later, LevitasBio has addressed the desire for scalability often expressed by researchers, both in the number of samples and cells that can be levitated and accessed. The new LeviCell EOS system provides a fourfold increase in sample throughput and allows up to four LeviCell EOS modules to be interconnected and independently controlled, increasing total scalability by 16 times. Researchers can now accelerate their discoveries with unprecedented sample processing power and insights.

A new era in sample processing

The LeviCell EOS System introduces several new features that enhance unbiased sample processing to optimize the study of natural biology. The first is a built-in thermal control system, which allows users to select from a range of predefined temperatures, ensuring that samples are processed at ideal temperatures to maintain cell states.

In addition, an advanced, fully cross-linked imaging system enables powerful, real-time sample characterization analysis during processing. Important insights such as fractionation, cell counts, viability assessment, and quality measurements can be reviewed in real time, allowing researchers to make informed decisions about how best to use their enriched samples in downstream studies .

Finally, the LeviCell EOS system offers unprecedented flexibility with a modular and interchangeable EOS Magnetic Core. A growing family of selectable core modules will enable a wide range of specifically optimized applications on a single platform.


“We are changing the landscape of how researchers conduct their experiments”, “The new LeviCell EOS system paves the way for fully integrated methods in sample processing and precise characterization at scaled throughputs. This marks a profound change in the way scientists work with their samples.”

— Martin Pieprzyk, CEO of LevitasBio

Next Post

5G in Healthcare Market to Witness Huge Growth by 2026

The Latest research study released by Market Intellix “5G in Healthcare market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in […]